Real-time MRI-guided percutaneous sclerotherapy treatment of venous low-flow malformations in the head and neck

Sasan Partovi, Ziang Lu, Lorenna Vidal, Dean A. Nakamoto, Ji Buethe, Michael Coffey, Indravadan J. Patel

Research output: Contribution to journalArticle

Abstract

Purpose: This manuscript describes the technique of real-time MRI-guided sclerotherapy for low-flow venous malformations in the head and neck based on our institutional experience. Materials and methods: Ethanolamine oleate is used as the sclerosant and is mixed with gadolinium for visualization during the procedure. The five procedural steps include: (I) an initial tri-plane T2-weighted sequence to visualize the lesion; (II) a T1 FSE or trueFISP sequence to assess needle placement and advancement within the lesion; (III) a tri-plane T1 FLASH sequence to monitor sclerosant injection; (IV) a T1 FSE or VIBE sequence to assess sclerosant coverage of the malformation before needle removal; (V) a post-procedural tri-plane T1 fat-saturated sequence to confirm sclerosant coverage of the lesion. Periprocedural medications typically include steroids, antibiotic prophylaxis, and non-steroidal anti-inflammatory medication. Patients are typically admitted for overnight observation. Conclusion: Real-time MRI-guided sclerotherapy for low-flow venous malformations in the head and neck is effective and safe.

Original languageEnglish (US)
JournalPhlebology
DOIs
StateAccepted/In press - Jan 1 2017

Fingerprint

Sclerosing Solutions
Sclerotherapy
Neck
Head
Needles
Antibiotic Prophylaxis
Gadolinium
Therapeutics
Anti-Inflammatory Agents
Fats
Steroids
Observation
Injections

Keywords

  • Ethanolamine Oleate
  • MRI guidance
  • percutaneous sclerotherapy
  • real-time
  • Venous malformation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Real-time MRI-guided percutaneous sclerotherapy treatment of venous low-flow malformations in the head and neck. / Partovi, Sasan; Lu, Ziang; Vidal, Lorenna; Nakamoto, Dean A.; Buethe, Ji; Coffey, Michael; Patel, Indravadan J.

In: Phlebology, 01.01.2017.

Research output: Contribution to journalArticle

Partovi, Sasan ; Lu, Ziang ; Vidal, Lorenna ; Nakamoto, Dean A. ; Buethe, Ji ; Coffey, Michael ; Patel, Indravadan J. / Real-time MRI-guided percutaneous sclerotherapy treatment of venous low-flow malformations in the head and neck. In: Phlebology. 2017.
@article{c05ede603f80459e9932383e25f83af3,
title = "Real-time MRI-guided percutaneous sclerotherapy treatment of venous low-flow malformations in the head and neck",
abstract = "Purpose: This manuscript describes the technique of real-time MRI-guided sclerotherapy for low-flow venous malformations in the head and neck based on our institutional experience. Materials and methods: Ethanolamine oleate is used as the sclerosant and is mixed with gadolinium for visualization during the procedure. The five procedural steps include: (I) an initial tri-plane T2-weighted sequence to visualize the lesion; (II) a T1 FSE or trueFISP sequence to assess needle placement and advancement within the lesion; (III) a tri-plane T1 FLASH sequence to monitor sclerosant injection; (IV) a T1 FSE or VIBE sequence to assess sclerosant coverage of the malformation before needle removal; (V) a post-procedural tri-plane T1 fat-saturated sequence to confirm sclerosant coverage of the lesion. Periprocedural medications typically include steroids, antibiotic prophylaxis, and non-steroidal anti-inflammatory medication. Patients are typically admitted for overnight observation. Conclusion: Real-time MRI-guided sclerotherapy for low-flow venous malformations in the head and neck is effective and safe.",
keywords = "Ethanolamine Oleate, MRI guidance, percutaneous sclerotherapy, real-time, Venous malformation",
author = "Sasan Partovi and Ziang Lu and Lorenna Vidal and Nakamoto, {Dean A.} and Ji Buethe and Michael Coffey and Patel, {Indravadan J.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1177/0268355517710110",
language = "English (US)",
journal = "Phlebology",
issn = "1433-3031",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Real-time MRI-guided percutaneous sclerotherapy treatment of venous low-flow malformations in the head and neck

AU - Partovi, Sasan

AU - Lu, Ziang

AU - Vidal, Lorenna

AU - Nakamoto, Dean A.

AU - Buethe, Ji

AU - Coffey, Michael

AU - Patel, Indravadan J.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Purpose: This manuscript describes the technique of real-time MRI-guided sclerotherapy for low-flow venous malformations in the head and neck based on our institutional experience. Materials and methods: Ethanolamine oleate is used as the sclerosant and is mixed with gadolinium for visualization during the procedure. The five procedural steps include: (I) an initial tri-plane T2-weighted sequence to visualize the lesion; (II) a T1 FSE or trueFISP sequence to assess needle placement and advancement within the lesion; (III) a tri-plane T1 FLASH sequence to monitor sclerosant injection; (IV) a T1 FSE or VIBE sequence to assess sclerosant coverage of the malformation before needle removal; (V) a post-procedural tri-plane T1 fat-saturated sequence to confirm sclerosant coverage of the lesion. Periprocedural medications typically include steroids, antibiotic prophylaxis, and non-steroidal anti-inflammatory medication. Patients are typically admitted for overnight observation. Conclusion: Real-time MRI-guided sclerotherapy for low-flow venous malformations in the head and neck is effective and safe.

AB - Purpose: This manuscript describes the technique of real-time MRI-guided sclerotherapy for low-flow venous malformations in the head and neck based on our institutional experience. Materials and methods: Ethanolamine oleate is used as the sclerosant and is mixed with gadolinium for visualization during the procedure. The five procedural steps include: (I) an initial tri-plane T2-weighted sequence to visualize the lesion; (II) a T1 FSE or trueFISP sequence to assess needle placement and advancement within the lesion; (III) a tri-plane T1 FLASH sequence to monitor sclerosant injection; (IV) a T1 FSE or VIBE sequence to assess sclerosant coverage of the malformation before needle removal; (V) a post-procedural tri-plane T1 fat-saturated sequence to confirm sclerosant coverage of the lesion. Periprocedural medications typically include steroids, antibiotic prophylaxis, and non-steroidal anti-inflammatory medication. Patients are typically admitted for overnight observation. Conclusion: Real-time MRI-guided sclerotherapy for low-flow venous malformations in the head and neck is effective and safe.

KW - Ethanolamine Oleate

KW - MRI guidance

KW - percutaneous sclerotherapy

KW - real-time

KW - Venous malformation

UR - http://www.scopus.com/inward/record.url?scp=85039854808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039854808&partnerID=8YFLogxK

U2 - 10.1177/0268355517710110

DO - 10.1177/0268355517710110

M3 - Article

C2 - 28516809

AN - SCOPUS:85039854808

JO - Phlebology

JF - Phlebology

SN - 1433-3031

ER -